[1]赫军,李冬冬,禹建春,等.综合疗法治疗老年原发性骨质疏松症[J].中医正骨,2017,29(12):56-58.
点击复制

综合疗法治疗老年原发性骨质疏松症()
分享到:

《中医正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第29卷
期数:
2017年12期
页码:
56-58
栏目:
临床报道
出版日期:
2017-12-20

文章信息/Info

作者:
赫军李冬冬禹建春方苏亭孙捷
浙江省台州市博爱医院,浙江 台州 318050
关键词:
骨质疏松 综合疗法
摘要:
目的:观察综合疗法治疗老年原发性骨质疏松症的临床疗效及安全性。方法:2015年6月至2017年8月,采用健康指导、口服西药及中药治疗老年原发性骨质疏松症患者30例。男2例,女28例。年龄73~97岁,中位数78.5岁。病程4个月至6年,中位数14.5个月。健康指导贯穿于整个治疗过程。碳酸钙D3片,每日1片,晚睡前口服; 阿仑膦酸钠片,每周1片,晨起空腹口服,服后禁食30 min; 自拟中药固本强骨饮,每日1剂,早晚各服用1次; 30 d为1个疗程,连续治疗3个疗程。采用《中药新药临床研究指导原则(试行)》中骨质疏松症的症状分级量化表评定中医证候积分,测定患者的骨密度、血清钙和血清磷含量,采用视觉模拟量表(visual analogue scale,VAS)评定腰背部疼痛情况,采用《中药新药临床研究指导原则(试行)》中骨质疏松症的证候疗效判定标准评价综合疗效。治疗期间观察不良反应发生情况。结果:治疗3个疗程后,30例患者的中医证候积分、血清钙含量、血清磷含量及腰背部疼痛VAS评分均较治疗前下降[(12.09±4.89)分,(8.36±3.78)分,t=3.017,P=0.002;(26.07±1.56)mg·dL-1,(14.60±2.35)mg·dL-1,t=3.012,P=0.002;(25.06±1.01)mg·dL-1,(13.31±1.02)mg·dL-1,t=3.002,P=0.002;(8.86±1.14)分,(3.81±1.02)分,t=2.032,P=0.002],骨密度较治疗前增高[(0.69±0.15)g·cm-2,(0.81±0.15)g·cm-2,t=2.013,P=0.001]; 按照上述证候疗效标准评价综合疗效,临床痊愈1例、显效10例、有效16例、无效3例。治疗期间出现便溏2例、食欲下降2例、恶心及干呕1例,均未进行特殊处理,自然缓解。结论:综合疗法治疗老年原发性骨质疏松症,可以调节血清钙和血清磷含量,提高骨密度,减轻腰背部疼痛,具有综合疗效好、安全性高的优点。

参考文献/References:

[1] MAJUMDAR SR,LESLIEW WD,LIX LM,et al.Longer duration of diabetes strongly impacts fracture risk assessment:the Manitoba BMD cohort[J].J Clin Endocrinol Metab,2016,101(11):4489-4496.
[2] BECKERLEG W,OOMMEN RA.Osteoporosis management in residential care:How internal and family medicine resident physicians translate evidence into practice[J].Can Fam Physician,2017,63(5):411-412.
[3] LIU M,ZHANGY,CHENG X,et al.The effect of age on the changes in bone mineral density and osteoporosis detection rates in Han Chinese men over the age of 50[J].Aging Male,2014,17(3):166-173.
[4] SALE JE,BEATON D,BOGOCH E.Secondary prevention after an osteoporosis-related fracture:an overview[J].Clin Geriatr Med,2014,30(2):317-332.
[5] 张智海,刘忠厚,李娜,等.中国人骨质疏松症诊断标准专家共识(第三稿·2014版)[J].中国骨质疏松杂志,2014,20(9):1007-1010.
[6] 国家中医药管理局.中医内科病证诊断疗效标准(十六)[J].湖北中医杂志,2003,25(10):封三.
[7] 郑莜萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:357-358.
[8] 张智海,刘忠厚,石少辉,等.中国大陆地区以-2.5SD为诊断的骨质疏松症发病率文献回顾性研究[J].中国骨质疏松杂志,2015,21(1):1-7.
[9] 陈林,程军,李波,等.渝东北地区老年人骨质疏松流行病学调查[J].中国骨质疏松杂志,2016,22(8):1050-1052.
[10] ABDI F,MOBEDI H,BAYAT F,et al.The effects of transdermal estrogen delivery on bone mineral density in postmenopausal women:a meta-analysis[J].Iran J Pharm Res,2017,16(1):380-389.
[11] 石陨.膏方调治骨质疏松症探析[J].中医正骨,2016,28(6):53-55.
[12] 邢润麟,王培民,张农山,等.中医“肝肾同源”理论异病同治膝骨关节炎和绝经后骨质疏松症的实验理论基础研究[J].中医正骨,2017,29(1):1-10.
[13] 黄易之,卢新刚,瞿佶,等.中医药治疗老年骨质疏松症研究进展[J].老年医学与保健,2015,21(2):119-120.
[14] 张震宇,侯勇,王冠,等.运动对预防老年骨质疏松性骨折的作用[J].中国老年学杂志,2013,33(8):1977-1978.
[15] 孙玉敏,李媛.中药防治骨质疏松的研究进展[J].医学综述,2016,22(17):3448-3450.
[16] 王昭洪,曾涛.补肾中药治疗骨质疏松的实验研究进展[J].环球中医药,2011,4(3):235-238.
[17] 王翔,石印玉.补肾中药防治骨质疏松症基础研究进展[J].中医正骨,2003,15(3):52-54.
[18] 严红梅,张振海,孙娥,等.中药治疗骨质疏松症的研究进展[J].中草药,2014,45(8):1174-1178.
[19] 史晓林,王健,王博,等.虚瘀兼顾--治疗原发性骨质疏松症的基本原则[J].中医正骨,2017,29(3):14-16.
[20] 王洁,王萧枫.淫羊藿总黄酮的抗骨质疏松作用及其对调控成骨细胞分化及骨形成关键信号通路的影响[J].中医正骨,2017,29(1):45-48.
[21] 黄宏兴,陈彦东.中西医结合防治骨质疏松症的研究思路与方法[J].中医正骨,2008,20(3):74-75.

相似文献/References:

[1]李林军.应用膨胀式椎弓根螺钉内固定治疗合并骨质疏松的 胸腰椎退行性疾病[J].中医正骨,2015,27(08):49.
[2]韩艳,温利平,刘娜,等.补肾活血方对去卵巢大鼠骨代谢及骨密度的影响[J].中医正骨,2015,27(12):7.
 HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(补肾活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(12):7.
[3]李学朋,朱立国.骨疏康胶囊对去卵巢大鼠骨小梁的影响[J].中医正骨,2015,27(12):12.
 LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康胶囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(12):12.
[4]陈冠军,陈扬,庄汝杰.可灌注骨水泥椎弓根螺钉系统 在老年腰椎疾患手术中的应用[J].中医正骨,2015,27(02):40.
[5]王丹辉,贲越,韩梅.林蛙油治疗绝经后骨质疏松症的临床研究[J].中医正骨,2014,26(01):27.
 Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(12):27.
[6]黄建华,黄建武,李慧辉,等.加味左归丸对绝经后骨质疏松症肝肾不足证 患者骨密度的影响[J].中医正骨,2013,25(11):19.
 Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(12):19.
[7]项旻,杨虹,林爱菊,等.绝经后2型糖尿病患者骨质疏松与血微量元素的关系研究[J].中医正骨,2013,25(12):20.
 Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(12):20.
[8]史晓林,李春雯,张志强.弱阳离子磁珠分离技术和基质辅助激光解吸电离飞行时间质谱技术在原发性Ⅰ型骨质疏松症血清标志蛋白筛选中的应用[J].中医正骨,2014,26(03):5.
 Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(12):5.
[9]李明,徐明雄,冯左基,等.自拟壮骨方治疗绝经后骨质疏松症的疗效及作用机制研究[J].中医正骨,2014,26(09):21.
 Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(12):21.
[10]陈俊杰,李晴晴,夏瑢.脂代谢及血清内脂素水平与绝经后骨质疏松症的 相关性研究[J].中医正骨,2012,24(04):16.
 CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(12):16.

更新日期/Last Update: 2018-05-02